Literature DB >> 19959782

Cardiac fibroblast: the renaissance cell.

Colby A Souders1, Stephanie L K Bowers, Troy A Baudino.   

Abstract

The permanent cellular constituents of the heart include cardiac fibroblasts, myocytes, endothelial cells, and vascular smooth muscle cells. Previous studies have demonstrated that there are undulating changes in cardiac cell populations during embryonic development, through neonatal development and into the adult. Transient cell populations include lymphocytes, mast cells, and macrophages, which can interact with these permanent cell types to affect cardiac function. It has also been observed that there are marked differences in the makeup of the cardiac cell populations depending on the species, which may be important when examining myocardial remodeling. Current dogma states that the fibroblast makes up the largest cell population of the heart; however, this appears to vary for different species, especially mice. Cardiac fibroblasts play a critical role in maintaining normal cardiac function, as well as in cardiac remodeling during pathological conditions such as myocardial infarct and hypertension. These cells have numerous functions, including synthesis and deposition of extracellular matrix, cell-cell communication with myocytes, cell-cell signaling with other fibroblasts, as well as with endothelial cells. These contacts affect the electrophysiological properties, secretion of growth factors and cytokines, as well as potentiating blood vessel formation. Although a plethora of information is known about several of these processes, relatively little is understood about fibroblasts and their role in angiogenesis during development or cardiac remodeling. In this review, we provide insight into the various properties of cardiac fibroblasts that helps illustrate their importance in maintaining proper cardiac function, as well as their critical role in the remodeling heart.

Entities:  

Mesh:

Year:  2009        PMID: 19959782      PMCID: PMC3345531          DOI: 10.1161/CIRCRESAHA.109.209809

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  190 in total

Review 1.  Myofibroblasts. I. Paracrine cells important in health and disease.

Authors:  D W Powell; R C Mifflin; J D Valentich; S E Crowe; J I Saada; A B West
Journal:  Am J Physiol       Date:  1999-07

Review 2.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

3.  Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts.

Authors:  C Ruwhof; A E van Wamel; J M Egas; A van der Laarse
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

Review 4.  Structural and functional characterisation of cardiac fibroblasts.

Authors:  Patrizia Camelliti; Thomas K Borg; Peter Kohl
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

5.  ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts.

Authors:  M Sano; K Fukuda; T Sato; H Kawaguchi; M Suematsu; S Matsuda; S Koyasu; H Matsui; K Yamauchi-Takihara; M Harada; Y Saito; S Ogawa
Journal:  Circ Res       Date:  2001-10-12       Impact factor: 17.367

6.  Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution.

Authors:  A C Nag
Journal:  Cytobios       Date:  1980

7.  Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts.

Authors:  Randy T Cowling; Xiaowei Zhang; Vanessa C Reese; Michikado Iwata; Devorah Gurantz; Wolfgang H Dillmann; Barry H Greenberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-05-06       Impact factor: 4.733

8.  Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.

Authors:  Romana S Mughal; Philip Warburton; David J O'Regan; Stephen G Ball; Neil A Turner; Karen E Porter
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-10-08       Impact factor: 2.557

Review 9.  Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues.

Authors:  Giulio Cossu; Paolo Bianco
Journal:  Curr Opin Genet Dev       Date:  2003-10       Impact factor: 5.578

10.  Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo.

Authors:  Barbara Coles; Ceri A Fielding; Stefan Rose-John; Jürgen Scheller; Simon A Jones; Valerie B O'Donnell
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more
  357 in total

Review 1.  A-kinase anchoring proteins that regulate cardiac remodeling.

Authors:  Graeme K Carnegie; Brian T Burmeister
Journal:  J Cardiovasc Pharmacol       Date:  2011-11       Impact factor: 3.105

2.  c-Myc is required for proper coronary vascular formation via cell- and gene-specific signaling.

Authors:  Colby A Souders; Stephanie L K Bowers; Indroneal Banerjee; John W Fuseler; Jennifer L Demieville; Troy A Baudino
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-08       Impact factor: 8.311

3.  ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors.

Authors:  David Lu; Sahar Soleymani; Rohit Madakshire; Paul A Insel
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

4.  Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valentina Kon; Agnes B Fogo; Daniel A Lawrence; Ji Ma
Journal:  Lab Invest       Date:  2014-03-31       Impact factor: 5.662

5.  Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis.

Authors:  Ping Kong; Panagiota Christia; Amit Saxena; Ya Su; Nikolaos G Frangogiannis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-30       Impact factor: 4.733

Review 6.  Fibroblasts in myocardial infarction: a role in inflammation and repair.

Authors:  Arti V Shinde; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2013-12-07       Impact factor: 5.000

Review 7.  Cardiac fibroblasts : Active players in (atrial) electrophysiology?

Authors:  Alexander Klesen; Dorothee Jakob; Ramona Emig; Peter Kohl; Ursula Ravens; Rémi Peyronnet
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-02-01

8.  Insulin Cannot Induce Adipogenic Differentiation in Primary Cardiac Cultures.

Authors:  Sreejit Parameswaran; Rajendra K Sharma
Journal:  Int J Angiol       Date:  2016-01-14

9.  Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis.

Authors:  Padmini Sirish; Ning Li; Jun-Yan Liu; Kin Sing Stephen Lee; Sung Hee Hwang; Hong Qiu; Cuifen Zhao; Siu Mei Ma; Javier E López; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

10.  Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts.

Authors:  Hassan Musa; Kuljeet Kaur; Ryan O'Connell; Matt Klos; Guadalupe Guerrero-Serna; Uma Mahesh R Avula; Todd J Herron; Jerômé Kalifa; Justus M B Anumonwo; José Jalife
Journal:  Heart Rhythm       Date:  2013-03-14       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.